DIFLUPREDNATE
NDC 69315-329, DIFLUPREDNATE, emulsion, from Leading Pharma, LLC.
- Product NDC
- 69315-329
- Status
- Listed
- Labeler
- Leading Pharma, LLC
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219441
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69315-329 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIFLUPREDNATE.5 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69315-329-05 | 69315032905 | 1 BOTTLE in 1 CARTON (69315-329-05) / 5 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/054ca798-454a-41cc-9d08-97bb8bef5620NADAC price for package 69315032905
GET /v1/drugs/nadac/69315032905
Use it
Look up 69315-329 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69315-329 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69315-329. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.